Status:
UNKNOWN
Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness
Lead Sponsor:
University Hospital, Bonn
Collaborating Sponsors:
The German-Israeli Foundation for Scientific Research and Development
Prof. Simone Shamay-Tsoory, University of Haifa
Conditions:
Loneliness
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the clinical potential of oxytocin (OT) as an adjunct to a cognitive-behavioral group-based shortterm intervention for participants suffering from loneliness.
Detailed Description
Loneliness has a high prevalence in Western societies and poses a significant health problem. Among its many implications, loneliness has been associated with increased risk for coronary heart disease...
Eligibility Criteria
Inclusion
- UCLA loneliness scale score equal to or greater than 55
Exclusion
- current psychiatric illness
- current psychiatric medication or psychotherapy
- MRI contraindication (e.g. metal in body, claustrophobia)
- pregnancy
Key Trial Info
Start Date :
September 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04137432
Start Date
September 26 2019
End Date
December 1 2020
Last Update
October 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, University of Bonn
Bonn, Germany, 53105